GlassScriptPhysician profile
Nadia Lynne Strucko
NPI 1912139759
$2,290.62
in general payments reported to CMS, 2019-2025
19 companies · $73.97 in 2025
The $73.97 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $319 · 2021: $160 · 2022: $503 · 2023: $367 · 2024: $355 · 2025: $73.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $457.36 | 2019-2024 | Total30 |
| Maculogix, INC. | $300.78 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $297.61 | 2023-2025 | Infuse, Miebo, Xiidra |
| Optos, INC. | $259.19 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $239.62 | 2020-2023 | |
| Shire North American Group INC | $177.48 | 2019 | |
| Coopervision INC. | $163.35 | 2022-2024 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $81.39 | 2022-2023 | Tyrvaya |
| Harrow Eye, LLC | $63.69 | 2024-2025 | Vevye |
| Dompe US, INC. | $54.39 | 2022-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $37.77 | 2021-2023 | Cequa |
| Biotissue Holdings INC. | $28.67 | 2021-2024 | |
| Johnson & Johnson Vision Care, INC. | $27.83 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $25.17 | 2024 | Xdemvy |
| Sight Sciences, INC. | $19.26 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.85 | 2022 | |
| Kala Pharmaceuticals, INC. | $16.57 | 2021 | |
| Spark Therapeutics, INC. | $13.20 | 2022 | |
| Abb Con-Cise Optical Group LLC | $9.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Strucko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.